Shasun Pharmaceuticals is locked in upper circuit for second straight day, up 10% at Rs 165 on the NSE, after Morgan Stanley Asia bought nearly one per cent stake in the company for a total consideration of Rs 5.9 crore.
According to the bulk deal data of National Stock Exchange, Morgan Stanley Asia has bought 402,545 representing 0.71% total equity capital of the company for Rs 146.86 per equity share.
Meanwhile, the pharmaceutical stock has rallied 29% in past three trading sessions from Rs 128 on May 5, after the company announced a joint venture into veterinary products business and acquisition of rights to develop and sell an extended release of ibuprofen along with a brand.
At 1115 hours, a combined 2.57 million shares changed hands on the counter and there are pending buy orders for 330,427 shares on the NSE and BSE.
According to the bulk deal data of National Stock Exchange, Morgan Stanley Asia has bought 402,545 representing 0.71% total equity capital of the company for Rs 146.86 per equity share.
Meanwhile, the pharmaceutical stock has rallied 29% in past three trading sessions from Rs 128 on May 5, after the company announced a joint venture into veterinary products business and acquisition of rights to develop and sell an extended release of ibuprofen along with a brand.
At 1115 hours, a combined 2.57 million shares changed hands on the counter and there are pending buy orders for 330,427 shares on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%